Officials at the US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) offered clarifications related to the Q-submission program’s evolution during a recent ...
Considering the tight timeline for preparing responses to FDA compliance actions coupled with the agency’s expectation for timely implementation of corrective and preventive actions, the benefit of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results